Singapore markets closed

Rhythm Pharmaceuticals, Inc. (RYTM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
38.96+1.00 (+2.63%)
At close: 04:00PM EDT
39.00 +0.04 (+0.10%)
Pre-market: 04:54AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
91,926
77,428
23,638
3,154
0
Cost of revenue
10,688
9,302
2,133
599
0
Gross profit
81,238
68,126
21,505
2,555
0
Operating expenses
Research development
225,671
134,951
108,630
104,128
90,450
Selling general and administrative
127,280
117,532
92,032
68,486
46,125
Total operating expenses
352,951
252,483
200,662
172,614
136,575
Operating income or loss
-271,713
-184,357
-179,157
-170,059
-136,575
Interest expense
15,586
13,892
5,201
0
0
Total other income/expenses net
741
190
-790
100,000
-
Income before tax
-273,007
-184,114
-181,119
-69,612
-133,996
Income tax expense
864
564
0
0
-
Income from continuing operations
-273,871
-184,678
-181,119
-69,612
-133,996
Net income
-273,871
-184,678
-181,119
-69,612
-133,996
Net income available to common shareholders
-273,871
-184,678
-181,119
-69,612
-133,996
Basic EPS
-3.24
-3.20
-3.47
-1.40
-3.04
Diluted EPS
-3.24
-3.20
-3.47
-1.40
-3.04
Basic average shares
56,952
57,673
52,121
49,600
44,127
Diluted average shares
56,952
57,673
52,121
49,600
44,127